| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Vaxcyte, Inc.'s insiders have reduced their positions by a net 45,442 shares worth roughly $3.7M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 429.9K | $26.14M | - | |
| COO | 145.4K | $8.84M | - | |
| CFO | 95.3K | $5.80M | - | |
| Other | 68.1K | $4.14M | - | |
| Other | 52.6K | $3.20M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2024 | Mikhail Eydelman67 | SVP, Gen Counsel & Corp Sec | Sale+OE10b5-1 | 1,667 | $72.06 | $120,127.22 | -5.1% | +52.5% | -52.0% | |
| Jun 3, 2024 | Halley E Gilbert | Director | Sale+OE10b5-1 | 18,200 | $73.00 | $1,328,600.00 | -76.4% | +52.5% | -52.0% | |
| May 23, 2024 | Grant Pickering50 | Chief Executive Officer | Sale+OE10b5-1 | 15,000 | $69.43 | $1,041,407.63 | -3.0% | +15.2% | -53.0% | |
| May 20, 2024 | Andrew Guggenhime46 | President and CFO | Sale+OE10b5-1 | 8,000 | $74.99 | $599,909.18 | -7.7% | +4.1% | -51.8% | |
| May 1, 2024 | Grant Pickering50 | Chief Executive Officer | Sell10b5-1 | 2,616 | $61.70 | $161,419.23 | -1.8% | +25.4% | -44.7% | |
| May 1, 2024 | Mikhail Eydelman67 | SVP, Gen Counsel & Corp Sec | Sale+OE10b5-1 | 1,667 | $61.74 | $102,921.27 | -5.2% | +25.4% | -44.7% | |
| May 1, 2024 | Jim Wassil53 | Chief Operating Officer | Sell10b5-1 | 3,000 | $61.65 | $184,942.01 | -1.4% | +25.4% | -44.7% | |
| Apr 23, 2024 | Grant Pickering50 | Chief Executive Officer | Sale+OE10b5-1 | 15,000 | $61.92 | $928,845.00 | -3.0% | +38.1% | -45.5% | |
| Apr 18, 2024 | Andrew Guggenhime46 | President and CFO | Sale+OE10b5-1 | 8,000 | $61.27 | $490,199.41 | -7.7% | +34.2% | -49.4% | |
| Apr 1, 2024 | Mikhail Eydelman67 | SVP, Gen Counsel & Corp Sec | Sale+OE10b5-1 | 1,667 | $66.73 | $111,234.14 | -5.2% | +15.3% | -51.7% |